Outcome of Board Meeting dated May 15, 2026, for detailed disclosure please refer the PDF
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jupiter Life Line Hospitals reported consolidated revenue of Rs 14,997.87 million for FY2026, up 15.2% from Rs 13,024.02 million in FY2025. Net profit after tax grew marginally to Rs 1,941.87 million from Rs 1,937.54 million. The Board declared an interim dividend of Rs 1 per share (10%) with record date May 22, 2026. Additionally, the company announced a stock split - converting 1 share of Rs 10 face value into 5 shares of Rs 2 each. Key leadership changes include Dr. Ajay Thakker appointed as Chairman & Whole-Time Director, and two new senior managerial appointments. The statutory auditors issued an unmodified (clean) opinion on both standalone and consolidated financials. An exceptional item of Rs 48.87 million was recorded due to increased gratuity liability from new labour codes.
Revenue growth of 15% is solid but slightly below 20% threshold; PAT remained flat which may disappoint growth-focused investors. The stock split makes shares more affordable for retail investors. The clean audit and dividend declaration are positive signals for shareholder confidence.